心力衰竭的全球经济负担评估
该研究系统检索四个数据库,纳入报告心力衰竭直接成本(DC)和/或间接成本(IC)的研究,并按人类发展指数(HDI)对国家分组加权估算2021年经济负担。极高HDI国家绝对支出最多但占CHE和GDP比例较低,低HDI国家负担相对更重。
要点
- 极高HDI国家绝对心衰支出最多,但DC仅占CHE 1.07%、IC占GDP 0.09%。
- 低HDI国家心衰DC占CHE 8.85%、IC占GDP 0.29%,相对负担更重。
核心结论
- 心衰全球经济负担巨大且呈增长趋势,各国间存在差异。
- 极高和高HDI国家承担大部分绝对成本,低HDI国家相对其CHE或GDP负担不成比例。
- 低HDI地区数据稀缺,妨碍准确的负担估算。
研究设计与样本
- 按PRISMA指南系统检索四个数据库,纳入报告心衰DC和/或IC的研究。
- DC和IC以占2021年CHE和GDP的百分比表示,数据来自WHO全球卫生支出数据库。
主要发现
- 极高HDI国家DC占CHE 1.07%、IC占GDP 0.09%,低HDI国家分别为8.85%和0.29%。
临床怎么用
- 各国应制定适合自身医疗系统的主动且具成本效益的措施以优化心衰诊疗。
- 关注低HDI国家相对CHE和GDP的过高心衰负担,并改善其数据收集。
局限性
- 低HDI地区数据稀缺,妨碍准确的负担估算。
- 仅基于2021年支出数据估算,可能受当年经济与卫生支出波动影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Heart failure (HF) is a major public health issue, imposing substantial costs on healthcare systems and societies. This study aimed to provide a contemporary overview of its global economic impact. METHODS: A systematic search of four databases was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies reporting direct cost (DC) and/or indirect cost (IC) associated with HF were included. DC and IC were expressed as a percentage of current healthcare expenditure (CHE) and gross domestic product (GDP), which were obtained for 2021 from the World Health Organization Global Health Expenditure Database. Countries were categorized by their Human Development Index (HDI), and weighted group means were calculated to estimate costs based on their 2021 expenditure. RESULTS: Thirty-two studies met the inclusion criteria. In 2021, the estimated economic burden of HF was $284.17 billion across 179 countries. This included $136.86 billion (48.16%) in DC and $147.31 (51.84%) billion in IC. Very high HDI countries account for most absolute HF spending, but HF comprises a smaller share of CHE and GDP (1.07% DC, 0.09% IC) compared with low HDI countries (8.85% DC, 0.29% IC). CONCLUSIONS: The global economic burden of HF is substantial, increasing, and varies across countries. Although very high and high HDI countries carry most of the absolute costs, low HDI countries bear a disproportionate burden relative to their total healthcare expenditure or GDP. Data scarcity in these settings further impedes accurate burden estimates. To address this growing challenge, proactive and cost-effective measures tailored to each country's healthcare system are crucial in optimizing HF care worldwide.
引用
- Darvish, Shakoor, Feyz, et al. Heart failure: assessment of the global economic burden. Eur Heart J. 2025. PMID: 40444781. doi:10.1093/eurheartj/ehaf323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。